Eva Kohegyi
Senior Director
Otsuka

Eva Kohegyi, M.D. MS, joined Otsuka Pharmaceutical Development & Commercialization, Inc. in 2009, and now works as an Executive Director in Global Clinical Development, CNS. She serves as Medical/Project Lead on various CNS projects, including leading the clinical development of multiple pediatric, adult and elderly indications including schizophrenia, bipolar disorder, autism, Tourette’s disorder for pediatric and adolescent patients, PTSD and MDD for adults and agitation in Alzheimer’s disease for senior patients. She participated in various US and ROW submissions and agency meetings.
Eva joined Otsuka from Sanofi where she worked in international drug development in psychiatry in the psychiatric therapeutic area. Earlier in her career, Eva worked in psychiatry clinical research at UPENN and the Clinical Research Center of the Arthur P. Noyes Foundation in the Norristown State Hospital and at the beginning of her career practiced psychiatry in a hospital setting in Budapest, Hungary.
Eva completed this adult Psychiatry Residency training and earned her Doctor of Medicine degree at University of Semmelweis School of Medicine Budapest Hungary and earned her Master of Science degree in Pharmaceutical Regulatory Affairs from Temple University School of Pharmacy in Philadelphia PA.